Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23


Secular trends in fracture incidence in the UK between 1990 and 2012.

van der Velde RY, Wyers CE, Curtis EM, Geusens PP, van den Bergh JP, de Vries F, Cooper C, van Staa TP, Harvey NC.

Osteoporos Int. 2016 Nov;27(11):3197-3206.


Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status.

Curtis EM, van der Velde R, Moon RJ, van den Bergh JP, Geusens P, de Vries F, van Staa TP, Cooper C, Harvey NC.

Bone. 2016 Jun;87:19-26. doi: 10.1016/j.bone.2016.03.006. Epub 2016 Mar 9.


Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).

Grimaldi-Bensouda L, Klungel O, Kurz X, de Groot MC, Maciel Afonso AS, de Bruin ML, Reynolds R, Rossignol M.

BMJ Open. 2016 Jan 8;6(1):e009147. doi: 10.1136/bmjopen-2015-009147.


The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX® Algorithm.

Klop C, Welsing PM, Leufkens HG, Elders PJ, Overbeek JA, van den Bergh JP, Bijlsma JW, de Vries F.

PLoS One. 2015 Dec 3;10(12):e0143800. doi: 10.1371/journal.pone.0143800. eCollection 2015.


Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.

Bours S, de Vries F, van den Bergh JP, Lalmohamed A, van Staa TP, Leufkens HG, Geusens PP, Drent M, Harvey NC.

Osteoporos Int. 2016 Apr;27(4):1603-10. doi: 10.1007/s00198-015-3426-1. Epub 2015 Dec 2.


Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.

Freedberg DE, Haynes K, Denburg MR, Zemel BS, Leonard MB, Abrams JA, Yang YX.

Osteoporos Int. 2015 Oct;26(10):2501-7. doi: 10.1007/s00198-015-3168-0. Epub 2015 May 19.


Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis.

Driessen JH, Henry RM, van Onzenoort HA, Lalmohamed A, Burden AM, Prieto-Alhambra D, Neef C, Leufkens HG, de Vries F.

Calcif Tissue Int. 2015 Aug;97(2):104-12. doi: 10.1007/s00223-015-9993-5. Epub 2015 Apr 17.


Influence of drugs on vitamin D and calcium metabolism.

Gröber U, Kisters K.

Dermatoendocrinol. 2012 Apr 1;4(2):158-66. doi: 10.4161/derm.20731.


A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.

Bazelier MT, van Staa TP, Uitdehaag BM, Cooper C, Leufkens HG, Vestergaard P, Bentzen J, de Vries F.

Neurology. 2012 Aug 28;79(9):922-8. doi: 10.1212/WNL.0b013e318266faae. Epub 2012 Aug 15.


Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study.

Lalmohamed A, de Vries F, Bazelier MT, Cooper A, van Staa TP, Cooper C, Harvey NC.

BMJ. 2012 Aug 3;345:e5085. doi: 10.1136/bmj.e5085.


Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research.

Weiskopf NG, Weng C.

J Am Med Inform Assoc. 2013 Jan 1;20(1):144-51. doi: 10.1136/amiajnl-2011-000681. Epub 2012 Jun 25. Review.


"Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study".

Pagès-Castellà A, Carbonell-Abella C, Avilés FF, Alzamora M, Baena-Díez JM, Laguna DM, Nogués X, Díez-Pérez A, Prieto-Alhambra D.

BMC Musculoskelet Disord. 2012 May 28;13:79. doi: 10.1186/1471-2474-13-79.


Fracture rate in patients with myasthenia gravis: the general practice research database.

Pouwels S, de Boer A, Javaid MK, Hilton-Jones D, Verschuuren J, Cooper C, Leufkens HG, de Vries F.

Osteoporos Int. 2013 Feb;24(2):467-76. doi: 10.1007/s00198-012-1970-5. Epub 2012 Apr 25.


The risk of fracture in patients with multiple sclerosis: the UK general practice research database.

Bazelier MT, van Staa T, Uitdehaag BM, Cooper C, Leufkens HG, Vestergaard P, Bentzen J, de Vries F.

J Bone Miner Res. 2011 Sep;26(9):2271-9. doi: 10.1002/jbmr.418.


Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures.

Schelleman H, Pollard JR, Newcomb C, Markowitz CE, Bilker WB, Leonard MB, Hennessy S.

Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):619-25. doi: 10.1002/pds.2141.


Validity of diagnostic coding within the General Practice Research Database: a systematic review.

Khan NF, Harrison SE, Rose PW.

Br J Gen Pract. 2010 Mar;60(572):e128-36. doi: 10.3399/bjgp10X483562. Review.


The risk of fractures associated with thiazolidinediones: a self-controlled case-series study.

Douglas IJ, Evans SJ, Pocock S, Smeeth L.

PLoS Med. 2009 Sep;6(9):e1000154. doi: 10.1371/journal.pmed.1000154. Epub 2009 Sep 29.


The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK.

Cooper C, Steinbuch M, Stevenson R, Miday R, Watts NB.

Osteoporos Int. 2010 Apr;21(4):569-77. doi: 10.1007/s00198-009-1003-1. Epub 2009 Jun 23.


Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.

de Vries F, Souverein PC, Cooper C, Leufkens HG, van Staa TP.

Calcif Tissue Int. 2007 Feb;80(2):69-75. Epub 2007 Feb 2.


Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database.

Burnham JM, Shults J, Weinstein R, Lewis JD, Leonard MB.

Ann Rheum Dis. 2006 Aug;65(8):1074-9. Epub 2006 Apr 20.

Items per page

Supplemental Content

Support Center